APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Blue Eye Disease Vaccines

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Blue Eye Disease Vaccines Industry Growth and Trends Forecast to 2032

Report ID 173971740122 December 202599 pages

Choose your research edition.

Industry ResearchBlue Eye Disease Vaccines Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Blue Eye Disease Vaccines Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Blue Eye Disease Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Blue Eye Disease Vaccines Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Blue Eye Disease Vaccines Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Blue Eye Disease Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Blue Eye Disease Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Blue Eye Disease Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Blue Eye Disease Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Blue Eye Disease Vaccines include CAHIC, Ceva, Chopper Biology, DHN, MSD Animal Health, Boehringer Ingelheim, Qilu Animal and Ringpu Biology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Blue Eye Disease Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Blue Eye Disease Vaccines market size, estimates, and forecasts are presented in terms of sales volume (m units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Blue Eye Disease Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Blue Eye Disease Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Blue Eye Disease Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Blue Eye Disease Vaccines Market by Company

CAHIC

Ceva

Chopper Biology

DHN

MSD Animal Health

Boehringer Ingelheim

Qilu Animal

Ringpu Biology

Blue Eye Disease Vaccines Segment by Type

Live Vaccines

Killed Vaccines

Blue Eye Disease Vaccines Segment by Application

Piglets

Adult Pigs

Blue Eye Disease Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blue Eye Disease Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Blue Eye Disease Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blue Eye Disease Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Blue Eye Disease Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Blue Eye Disease Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Live Vaccines Table 2. Major Company of Killed Vaccines Table 3. Global Blue Eye Disease Vaccines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Blue Eye Disease Vaccines Sales by Type (2021-2026) & (m units) Table 5. Global Blue Eye Disease Vaccines Sales Market Share in Volume by Type (2021-2026) Table 6. Global Blue Eye Disease Vaccines Sales by Type (2021-2026) & (US$ Million) Table 7. Global Blue Eye Disease Vaccines Sales Market Share in Value by Type (2021-2026) Table 8. Global Blue Eye Disease Vaccines Price by Type (2021-2026) & (US$/k unit) Table 9. Global Blue Eye Disease Vaccines Sales by Type (2027-2032) & (m units) Table 10. Global Blue Eye Disease Vaccines Sales Market Share in Volume by Type (2027-2032) Table 11. Global Blue Eye Disease Vaccines Sales by Type (2027-2032) & (US$ Million) Table 12. Global Blue Eye Disease Vaccines Sales Market Share in Value by Type (2027-2032) Table 13. Global Blue Eye Disease Vaccines Price by Type (2027-2032) & (US$/k unit) Table 14. North America Blue Eye Disease Vaccines Sales by Type (2021-2026) & (m units) Table 15. North America Blue Eye Disease Vaccines Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Blue Eye Disease Vaccines Sales by Type (2021-2026) & (m units) Table 17. Europe Blue Eye Disease Vaccines Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Blue Eye Disease Vaccines Sales by Type (2021-2026) & (m units) Table 19. Asia-Pacific Blue Eye Disease Vaccines Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Blue Eye Disease Vaccines Sales by Type (2021-2026) & (m units) Table 21. Latin America Blue Eye Disease Vaccines Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Blue Eye Disease Vaccines Sales by Type (2021-2026) & (m units) Table 23. Middle East and Africa Blue Eye Disease Vaccines Sales by Type (2021-2026) & (US$ Million) Table 24. Blue Eye Disease Vaccines Industry Trends Table 25. Blue Eye Disease Vaccines Industry Drivers Table 26. Blue Eye Disease Vaccines Industry Opportunities and Challenges Table 27. Blue Eye Disease Vaccines Industry Restraints Table 28. Global Blue Eye Disease Vaccines Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Blue Eye Disease Vaccines Revenue Market Share by Company (2021-2026) Table 30. Global Blue Eye Disease Vaccines Sales by Company (2021-2026) & (m units) Table 31. Global Blue Eye Disease Vaccines Sales Share by Company (2021-2026) Table 32. Global Blue Eye Disease Vaccines Market Price by Company (2021-2026) & (US$/k unit) Table 33. Global Blue Eye Disease Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Blue Eye Disease Vaccines Major Company Production Sites and Headquarters Table 35. Global Blue Eye Disease Vaccines Company, Product Type & Application Table 36. Global Blue Eye Disease Vaccines Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Blue Eye Disease Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Blue Eye Disease Vaccines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Blue Eye Disease Vaccines Sales by Region (2021-2026) & (m units) Table 41. Global Blue Eye Disease Vaccines Sales Market Share in Volume by Region (2021-2026) Table 42. Global Blue Eye Disease Vaccines Sales by Region (2021-2026) & (US$ Million) Table 43. Global Blue Eye Disease Vaccines Sales Market Share in Value by Region (2021-2026) Table 44. Global Blue Eye Disease Vaccines Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 45. Global Blue Eye Disease Vaccines Sales by Region (2027-2032) & (m units) Table 46. Global Blue Eye Disease Vaccines Sales Market Share in Volume by Region (2027-2032) Table 47. Global Blue Eye Disease Vaccines Sales by Region (2027-2032) & (US$ Million) Table 48. Global Blue Eye Disease Vaccines Sales Market Share in Value by Region (2027-2032) Table 49. Global Blue Eye Disease Vaccines Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2027-2032) Table 50. Global Blue Eye Disease Vaccines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Blue Eye Disease Vaccines Sales by Application (2021-2026) & (m units) Table 52. Global Blue Eye Disease Vaccines Sales Market Share in Volume by Application (2021-2026) Table 53. Global Blue Eye Disease Vaccines Sales by Application (2021-2026) & (US$ Million) Table 54. Global Blue Eye Disease Vaccines Sales Market Share in Value by Application (2021-2026) Table 55. Global Blue Eye Disease Vaccines Price by Application (2021-2026) & (US$/k unit) Table 56. Global Blue Eye Disease Vaccines Sales by Application (2027-2032) & (m units) Table 57. Global Blue Eye Disease Vaccines Sales Market Share in Volume by Application (2027-2032) Table 58. Global Blue Eye Disease Vaccines Sales by Application (2027-2032) & (US$ Million) Table 59. Global Blue Eye Disease Vaccines Sales Market Share in Value by Application (2027-2032) Table 60. Global Blue Eye Disease Vaccines Price by Application (2027-2032) & (US$/k unit) Table 61. North America Blue Eye Disease Vaccines Sales by Application (2021-2026) & (m units) Table 62. North America Blue Eye Disease Vaccines Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Blue Eye Disease Vaccines Sales by Application (2021-2026) & (m units) Table 64. Europe Blue Eye Disease Vaccines Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Blue Eye Disease Vaccines Sales by Application (2021-2026) & (m units) Table 66. Asia-Pacific Blue Eye Disease Vaccines Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Blue Eye Disease Vaccines Sales by Application (2021-2026) & (m units) Table 68. Latin America Blue Eye Disease Vaccines Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Blue Eye Disease Vaccines Sales by Application (2021-2026) & (m units) Table 70. Middle East and Africa Blue Eye Disease Vaccines Sales by Application (2021-2026) & (US$ Million) Table 71. CAHIC Company Information Table 72. CAHIC Business Overview Table 73. CAHIC Blue Eye Disease Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 74. CAHIC Blue Eye Disease Vaccines Product Portfolio Table 75. CAHIC Recent Development Table 76. Ceva Company Information Table 77. Ceva Business Overview Table 78. Ceva Blue Eye Disease Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 79. Ceva Blue Eye Disease Vaccines Product Portfolio Table 80. Ceva Recent Development Table 81. Chopper Biology Company Information Table 82. Chopper Biology Business Overview Table 83. Chopper Biology Blue Eye Disease Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 84. Chopper Biology Blue Eye Disease Vaccines Product Portfolio Table 85. Chopper Biology Recent Development Table 86. DHN Company Information Table 87. DHN Business Overview Table 88. DHN Blue Eye Disease Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 89. DHN Blue Eye Disease Vaccines Product Portfolio Table 90. DHN Recent Development Table 91. MSD Animal Health Company Information Table 92. MSD Animal Health Business Overview Table 93. MSD Animal Health Blue Eye Disease Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 94. MSD Animal Health Blue Eye Disease Vaccines Product Portfolio Table 95. MSD Animal Health Recent Development Table 96. Boehringer Ingelheim Company Information Table 97. Boehringer Ingelheim Business Overview Table 98. Boehringer Ingelheim Blue Eye Disease Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 99. Boehringer Ingelheim Blue Eye Disease Vaccines Product Portfolio Table 100. Boehringer Ingelheim Recent Development Table 101. Qilu Animal Company Information Table 102. Qilu Animal Business Overview Table 103. Qilu Animal Blue Eye Disease Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 104. Qilu Animal Blue Eye Disease Vaccines Product Portfolio Table 105. Qilu Animal Recent Development Table 106. Ringpu Biology Company Information Table 107. Ringpu Biology Business Overview Table 108. Ringpu Biology Blue Eye Disease Vaccines Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 109. Ringpu Biology Blue Eye Disease Vaccines Product Portfolio Table 110. Ringpu Biology Recent Development Table 111. North America Blue Eye Disease Vaccines Market Size Growth Rate (CAGR) by Country (m units): 2021 VS 2025 VS 2032 Table 112. North America Blue Eye Disease Vaccines Sales by Country (2021-2026) & (m units) Table 113. North America Blue Eye Disease Vaccines Sales Market Share by Country (2021-2026) Table 114. North America Blue Eye Disease Vaccines Sales Forecast by Country (2027-2032) & (m units) Table 115. North America Blue Eye Disease Vaccines Sales Market Share Forecast by Country (2027-2032) Table 116. North America Blue Eye Disease Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. North America Blue Eye Disease Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 118. North America Blue Eye Disease Vaccines Market Share by Country (2021-2026) Table 119. North America Blue Eye Disease Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. North America Blue Eye Disease Vaccines Market Share Forecast by Country (2027-2032) Table 121. Europe Blue Eye Disease Vaccines Market Size Growth Rate (CAGR) by Country (m units): 2021 VS 2025 VS 2032 Table 122. Europe Blue Eye Disease Vaccines Sales by Country (2021-2026) & (m units) Table 123. Europe Blue Eye Disease Vaccines Sales Market Share by Country (2021-2026) Table 124. Europe Blue Eye Disease Vaccines Sales Forecast by Country (2027-2032) & (m units) Table 125. Europe Blue Eye Disease Vaccines Sales Market Share Forecast by Country (2027-2032) Table 126. Europe Blue Eye Disease Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Europe Blue Eye Disease Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 128. Europe Blue Eye Disease Vaccines Market Share by Country (2021-2026) Table 129. Europe Blue Eye Disease Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Europe Blue Eye Disease Vaccines Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Blue Eye Disease Vaccines Market Size Growth Rate (CAGR) by Country (m units): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Blue Eye Disease Vaccines Sales by Country (2021-2026) & (m units) Table 133. Asia-Pacific Blue Eye Disease Vaccines Sales Market Share by Country (2021-2026) Table 134. Asia-Pacific Blue Eye Disease Vaccines Sales Forecast by Country (2027-2032) & (m units) Table 135. Asia-Pacific Blue Eye Disease Vaccines Sales Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Blue Eye Disease Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Blue Eye Disease Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 138. Asia-Pacific Blue Eye Disease Vaccines Market Share by Country (2021-2026) Table 139. Asia-Pacific Blue Eye Disease Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Asia-Pacific Blue Eye Disease Vaccines Market Share Forecast by Country (2027-2032) Table 141. Latin America Blue Eye Disease Vaccines Market Size Growth Rate (CAGR) by Country (m units): 2021 VS 2025 VS 2032 Table 142. Latin America Blue Eye Disease Vaccines Sales by Country (2021-2026) & (m units) Table 143. Latin America Blue Eye Disease Vaccines Sales Market Share by Country (2021-2026) Table 144. Latin America Blue Eye Disease Vaccines Sales Forecast by Country (2027-2032) & (m units) Table 145. Latin America Blue Eye Disease Vaccines Sales Market Share Forecast by Country (2027-2032) Table 146. Latin America Blue Eye Disease Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Latin America Blue Eye Disease Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 148. Latin America Blue Eye Disease Vaccines Market Share by Country (2021-2026) Table 149. Latin America Blue Eye Disease Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Latin America Blue Eye Disease Vaccines Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Blue Eye Disease Vaccines Market Size Growth Rate (CAGR) by Country (m units): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Blue Eye Disease Vaccines Sales by Country (2021-2026) & (m units) Table 153. Middle East and Africa Blue Eye Disease Vaccines Sales Market Share by Country (2021-2026) Table 154. Middle East and Africa Blue Eye Disease Vaccines Sales Forecast by Country (2027-2032) & (m units) Table 155. Middle East and Africa Blue Eye Disease Vaccines Sales Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Blue Eye Disease Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Blue Eye Disease Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 158. Middle East and Africa Blue Eye Disease Vaccines Market Share by Country (2021-2026) Table 159. Middle East and Africa Blue Eye Disease Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Middle East and Africa Blue Eye Disease Vaccines Market Share Forecast by Country (2027-2032) Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. Blue Eye Disease Vaccines Distributors List Table 164. Blue Eye Disease Vaccines Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Blue Eye Disease Vaccines Image Figure 2. Global Blue Eye Disease Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Blue Eye Disease Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Blue Eye Disease Vaccines Sales (2021-2032) & (m units) Figure 5. Live Vaccines Image Figure 6. Global Live Vaccines Sales YoY Growth (2021-2032) & (m units) Figure 7. Killed Vaccines Image Figure 8. Global Killed Vaccines Sales YoY Growth (2021-2032) & (m units) Figure 9. Global Blue Eye Disease Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Blue Eye Disease Vaccines Market Share by Type 2025 VS 2032 Figure 11. North America Blue Eye Disease Vaccines Sales Market Share in Volume by Type in 2025 Figure 12. North America Blue Eye Disease Vaccines Sales Market Share in Value by Type in 2025 Figure 13. Europe Blue Eye Disease Vaccines Sales Market Share in Volume by Type in 2025 Figure 14. Europe Blue Eye Disease Vaccines Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Blue Eye Disease Vaccines Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Blue Eye Disease Vaccines Sales Market Share in Value by Type in 2025 Figure 17. Latin America Blue Eye Disease Vaccines Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Blue Eye Disease Vaccines Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Blue Eye Disease Vaccines Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Blue Eye Disease Vaccines Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Blue Eye Disease Vaccines Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Piglets Image Figure 24. Global Piglets Sales YoY Growth (2021-2032) & (m units) Figure 25. Adult Pigs Image Figure 26. Global Adult Pigs Sales YoY Growth (2021-2032) & (m units) Figure 27. Global Blue Eye Disease Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Blue Eye Disease Vaccines Market Share by Application 2025 VS 2032 Figure 29. North America Blue Eye Disease Vaccines Sales Market Share in Volume by Application in 2025 Figure 30. North America Blue Eye Disease Vaccines Sales Market Share in Value by Application in 2025 Figure 31. Europe Blue Eye Disease Vaccines Sales Market Share in Volume by Application in 2025 Figure 32. Europe Blue Eye Disease Vaccines Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Blue Eye Disease Vaccines Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Blue Eye Disease Vaccines Sales Market Share in Value by Application in 2025 Figure 35. Latin America Blue Eye Disease Vaccines Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Blue Eye Disease Vaccines Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Blue Eye Disease Vaccines Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Blue Eye Disease Vaccines Sales Market Share in Value by Application in 2025 Figure 39. North America Blue Eye Disease Vaccines Sales by Country: 2021 VS 2025 VS 2032 (m units) Figure 40. North America Blue Eye Disease Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Blue Eye Disease Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Blue Eye Disease Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Blue Eye Disease Vaccines Sales by Country: 2021 VS 2025 VS 2032 (m units) Figure 44. Europe Blue Eye Disease Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Blue Eye Disease Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Blue Eye Disease Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Blue Eye Disease Vaccines Sales by Country: 2021 VS 2025 VS 2032 (m units) Figure 48. Asia-Pacific Blue Eye Disease Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Blue Eye Disease Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Blue Eye Disease Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Blue Eye Disease Vaccines Sales by Country: 2021 VS 2025 VS 2032 (m units) Figure 52. Latin America Blue Eye Disease Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Blue Eye Disease Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Blue Eye Disease Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Blue Eye Disease Vaccines Sales by Country: 2021 VS 2025 VS 2032 (m units) Figure 56. Middle East and Africa Blue Eye Disease Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Blue Eye Disease Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Blue Eye Disease Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Blue Eye Disease Vaccines Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Blue Eye Disease Vaccines Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Live Vaccines
  • Killed Vaccines
Applications
  • Piglets
  • Adult Pigs
Companies covered
  • CAHIC
  • Ceva
  • Chopper Biology
  • DHN
  • MSD Animal Health
  • Boehringer Ingelheim
  • Qilu Animal
  • Ringpu Biology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Blue Eye Disease Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Blue Eye Disease Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Blue Eye Disease Vaccines Market by Type
  6. 1.3.1 Live Vaccines
  7. 1.3.2 Killed Vaccines
  8. 1.4 Global Blue Eye Disease Vaccines Market Size by Type
  9. 1.4.1 Global Blue Eye Disease Vaccines Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Blue Eye Disease Vaccines Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Blue Eye Disease Vaccines Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Blue Eye Disease Vaccines Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Blue Eye Disease Vaccines Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Blue Eye Disease Vaccines Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Blue Eye Disease Vaccines Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Blue Eye Disease Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Blue Eye Disease Vaccines Industry Trends
  2. 2.2 Blue Eye Disease Vaccines Industry Drivers
  3. 2.3 Blue Eye Disease Vaccines Industry Opportunities and Challenges
  4. 2.4 Blue Eye Disease Vaccines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Blue Eye Disease Vaccines Revenue (2021-2026)
  2. 3.2 Global Top Players by Blue Eye Disease Vaccines Sales (2021-2026)
  3. 3.3 Global Top Players by Blue Eye Disease Vaccines Price (2021-2026)
  4. 3.4 Global Blue Eye Disease Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Blue Eye Disease Vaccines Major Company Production Sites & Headquarters
  6. 3.6 Global Blue Eye Disease Vaccines Company, Product Type & Application
  7. 3.7 Global Blue Eye Disease Vaccines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Blue Eye Disease Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Blue Eye Disease Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Blue Eye Disease Vaccines Tier 1, Tier 2, and Tier 3
4 Blue Eye Disease Vaccines Regional Status and Outlook
  1. 4.1 Global Blue Eye Disease Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Blue Eye Disease Vaccines Historic Market Size by Region
  3. 4.2.1 Global Blue Eye Disease Vaccines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Blue Eye Disease Vaccines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Blue Eye Disease Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Blue Eye Disease Vaccines Forecasted Market Size by Region
  7. 4.3.1 Global Blue Eye Disease Vaccines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Blue Eye Disease Vaccines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Blue Eye Disease Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Blue Eye Disease Vaccines by Application
  1. 5.1 Blue Eye Disease Vaccines Market by Application
  2. 5.1.1 Piglets
  3. 5.1.2 Adult Pigs
  4. 5.2 Global Blue Eye Disease Vaccines Market Size by Application
  5. 5.2.1 Global Blue Eye Disease Vaccines Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Blue Eye Disease Vaccines Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Blue Eye Disease Vaccines Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Blue Eye Disease Vaccines Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Blue Eye Disease Vaccines Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Blue Eye Disease Vaccines Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Blue Eye Disease Vaccines Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Blue Eye Disease Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 CAHIC
  2. 6.1.1 CAHIC Company Information
  3. 6.1.2 CAHIC Business Overview
  4. 6.1.3 CAHIC Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 CAHIC Blue Eye Disease Vaccines Product Portfolio
  6. 6.1.5 CAHIC Recent Developments
  7. 6.2 Ceva
  8. 6.2.1 Ceva Company Information
  9. 6.2.2 Ceva Business Overview
  10. 6.2.3 Ceva Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Ceva Blue Eye Disease Vaccines Product Portfolio
  12. 6.2.5 Ceva Recent Developments
  13. 6.3 Chopper Biology
  14. 6.3.1 Chopper Biology Company Information
  15. 6.3.2 Chopper Biology Business Overview
  16. 6.3.3 Chopper Biology Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Chopper Biology Blue Eye Disease Vaccines Product Portfolio
  18. 6.3.5 Chopper Biology Recent Developments
  19. 6.4 DHN
  20. 6.4.1 DHN Company Information
  21. 6.4.2 DHN Business Overview
  22. 6.4.3 DHN Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 DHN Blue Eye Disease Vaccines Product Portfolio
  24. 6.4.5 DHN Recent Developments
  25. 6.5 MSD Animal Health
  26. 6.5.1 MSD Animal Health Company Information
  27. 6.5.2 MSD Animal Health Business Overview
  28. 6.5.3 MSD Animal Health Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 MSD Animal Health Blue Eye Disease Vaccines Product Portfolio
  30. 6.5.5 MSD Animal Health Recent Developments
  31. 6.6 Boehringer Ingelheim
  32. 6.6.1 Boehringer Ingelheim Company Information
  33. 6.6.2 Boehringer Ingelheim Business Overview
  34. 6.6.3 Boehringer Ingelheim Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Boehringer Ingelheim Blue Eye Disease Vaccines Product Portfolio
  36. 6.6.5 Boehringer Ingelheim Recent Developments
  37. 6.7 Qilu Animal
  38. 6.7.1 Qilu Animal Company Information
  39. 6.7.2 Qilu Animal Business Overview
  40. 6.7.3 Qilu Animal Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Qilu Animal Blue Eye Disease Vaccines Product Portfolio
  42. 6.7.5 Qilu Animal Recent Developments
  43. 6.8 Ringpu Biology
  44. 6.8.1 Ringpu Biology Company Information
  45. 6.8.2 Ringpu Biology Business Overview
  46. 6.8.3 Ringpu Biology Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Ringpu Biology Blue Eye Disease Vaccines Product Portfolio
  48. 6.8.5 Ringpu Biology Recent Developments
7 North America by Country
  1. 7.1 North America Blue Eye Disease Vaccines Sales by Country
  2. 7.1.1 North America Blue Eye Disease Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Blue Eye Disease Vaccines Sales by Country (2021-2026)
  4. 7.1.3 North America Blue Eye Disease Vaccines Sales Forecast by Country (2027-2032)
  5. 7.2 North America Blue Eye Disease Vaccines Market Size by Country
  6. 7.2.1 North America Blue Eye Disease Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Blue Eye Disease Vaccines Market Size by Country (2021-2026)
  8. 7.2.3 North America Blue Eye Disease Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Blue Eye Disease Vaccines Sales by Country
  2. 8.1.1 Europe Blue Eye Disease Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Blue Eye Disease Vaccines Sales by Country (2021-2026)
  4. 8.1.3 Europe Blue Eye Disease Vaccines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Blue Eye Disease Vaccines Market Size by Country
  6. 8.2.1 Europe Blue Eye Disease Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Blue Eye Disease Vaccines Market Size by Country (2021-2026)
  8. 8.2.3 Europe Blue Eye Disease Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Blue Eye Disease Vaccines Sales by Country
  2. 9.1.1 Asia-Pacific Blue Eye Disease Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Blue Eye Disease Vaccines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Blue Eye Disease Vaccines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Blue Eye Disease Vaccines Market Size by Country
  6. 9.2.1 Asia-Pacific Blue Eye Disease Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Blue Eye Disease Vaccines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Blue Eye Disease Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Blue Eye Disease Vaccines Sales by Country
  2. 10.1.1 South America Blue Eye Disease Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Blue Eye Disease Vaccines Sales by Country (2021-2026)
  4. 10.1.3 South America Blue Eye Disease Vaccines Sales Forecast by Country (2027-2032)
  5. 10.2 South America Blue Eye Disease Vaccines Market Size by Country
  6. 10.2.1 South America Blue Eye Disease Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Blue Eye Disease Vaccines Market Size by Country (2021-2026)
  8. 10.2.3 South America Blue Eye Disease Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Blue Eye Disease Vaccines Sales by Country
  2. 11.1.1 Middle East and Africa Blue Eye Disease Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Blue Eye Disease Vaccines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Blue Eye Disease Vaccines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Blue Eye Disease Vaccines Market Size by Country
  6. 11.2.1 Middle East and Africa Blue Eye Disease Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Blue Eye Disease Vaccines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Blue Eye Disease Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Blue Eye Disease Vaccines Value Chain Analysis
  2. 12.1.1 Blue Eye Disease Vaccines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Blue Eye Disease Vaccines Production Mode & Process
  7. 12.2 Blue Eye Disease Vaccines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Blue Eye Disease Vaccines Distributors
  10. 12.2.3 Blue Eye Disease Vaccines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst